Your Health, We Care
Anagrelide is indicated for the treatment of patients with thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events.
FDA，2021.10
LuciusVersionofAnagrelide:DosageandAdministration,Indications,PrecautionsIndicat···【more】
Release date：2025-12-02Recommended：19
Anagrelide is a drug used to treat thrombocythemia, primarily for abnormal eleva···【more】
Release date：2024-12-12Recommended：126
